Jacob B Allred Selected Research

Carboplatin (JM8)

1/2018	NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
12/2013	A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacob B Allred Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 08/2006
12	Melanoma (Melanoma, Malignant) 09/2022 - 08/2006
7	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2012
4	Multiple Myeloma 09/2011 - 01/2007
3	Uveal melanoma 01/2023 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020 - 01/2020
2	Fatigue 01/2019 - 01/2007
2	Neutropenia 04/2014 - 01/2007
1	Vesicular Stomatitis 01/2023
1	Cytokine Release Syndrome 01/2023
1	Leiomyosarcoma 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2020
1	Adenocarcinoma 01/2020
1	Leukemia 01/2019
1	Obesity 01/2019
1	Triple Negative Breast Neoplasms 04/2016
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Nevus (Nevi) 08/2014
1	Alopecia (Baldness) 04/2014
1	Brain Neoplasms (Brain Tumor) 04/2014
1	Dyspnea (Shortness of Breath) 04/2014
1	Leukopenia 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 08/2013
1	Disease Progression 02/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2007
1	Thrombocytopenia (Thrombopenia) 01/2007
1	Exanthema (Rash) 01/2007
1	Immunoglobulin Light-chain Amyloidosis 01/2007
1	Primary Myelofibrosis (Myelosclerosis) 08/2006
1	Anemia 08/2006

Drug/Important Bio-Agent (IBA)

3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 08/2014
3	Sirolimus (Rapamycin)FDA Link 09/2020 - 08/2014
3	VaccinesIBA 01/2020 - 08/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 04/2014
3	Everolimus FDA Link 01/2018 - 08/2014
3	Lenalidomide (CC 5013)FDA Link 10/2009 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2010
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023 - 08/2006
2	HhAntag691IBA 09/2020 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2012
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 12/2013
2	Capecitabine (Xeloda)FDA Link 04/2014 - 04/2012
2	pomalidomideIBA 09/2011 - 10/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2009 - 01/2007
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	olaparibIBA 01/2023
1	Interferon-betaIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AntigensIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	cabozantinibIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	Protein Subunit VaccinesIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	EmulsionsIBA 01/2020
1	glucopyranosyl lipid-AIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	EpitopesIBA 01/2019
1	resiquimodIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Cytostatic AgentsIBA 01/2018
1	IpilimumabIBA 12/2016
1	Histone Deacetylase InhibitorsIBA 04/2016
1	PanobinostatIBA 04/2016
1	Letrozole (Femara)FDA LinkGeneric 04/2016
1	Estrogen ReceptorsIBA 04/2016
1	Alkylating AgentsIBA 08/2014
1	TOR Serine-Threonine KinasesIBA 08/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Docetaxel (Taxotere)FDA Link 12/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2013
1	thymoglobulin FDA Link 08/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2013
1	Cladribine FDA LinkGeneric 08/2013
1	AnthracyclinesIBA 12/2012
1	afliberceptIBA 12/2012
1	taxaneIBA 12/2012
1	Trastuzumab (Herceptin)FDA Link 04/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2012
1	antineoplaston A10 (A 10)IBA 02/2010
1	Immunomodulating AgentsIBA 10/2009
1	Thalidomide (Thalomid)FDA Link 10/2009
1	Interleukin-4 (Interleukin 4)IBA 07/2007
1	CytokinesIBA 07/2007
1	Hemoglobins (Hemoglobin)IBA 08/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2006

Therapy/Procedure

8	Therapeutics 12/2021 - 08/2006
4	Drug Therapy (Chemotherapy) 01/2020 - 12/2013
2	Immunotherapy 01/2019 - 08/2006
1	Lymph Node Excision (Lymph Node Dissection) 09/2022
1	Adjuvant Chemotherapy 01/2019
1	Salvage Therapy 01/2017
1	Radiotherapy 01/2016
1	Premedication 04/2014
1	Neoadjuvant Therapy 12/2013
1	Injections 08/2006